List of Devices Companies in Florida - 30

Asana Medical focuses on the development and commercialization of medical devices for gastrointestinal applications.

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.

AT BIOREP, WE MAKE PRODUCTS THAT ENHANCE - AND SAVE - LIVES. Beginning with our shared passion for health, we believe in making life better by innovating and developing new biomedical tools, and improving and understanding surgical techniques.

BioTissue is the leader in innovative applications of human birth tissues for regenerative wound healing, aiming to improve patient outcomes. The company is committed to promoting regenerative healing through its birth tissue products.

Cordis is a medical devices company that specializes in cardiology equipment and healthcare technology.

.decimal® is a medical device manufacturer of patient-specific devices, including BolusECT® compensators for electron conformal therapy, FlexiBol custom silicone bolus for photon therapy, Virtual Moldroom services for electron cutout outsourcing, modulators for advanced Solid IMRT® delivery, as well as apertures and range compensators used in proton therapy. We have been providing radiation therapy products to hospitals and cancer centers across the United States for thirty-five years.

Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.

HDL Therapeutics is a clinical-stage company that researches, develops and commercializes therapeutics for the treatment of heart-related problems.

ImmunSYS is a clinical stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with late-stage metastatic prostate cancer and other metastatic solid tumor cancers. ImmunSYS is at the forefront of an entirely new approach to treating cancer. Our platform therapy has been shown to be effective in some metastatic cancers and may have wide applications as a cancer treatment for several solid tumor cancers, with the potential for cure in some patients. The company’s revolutionary therapy, YourVaccx™ utilizes a novel combination of controlled cell lysis and a triple-component immunotherapeutic drug. This new immunotherapy focused therapy is designed to empower the immune system to recognize and selectively attack cancer cells throughout the body. The company is initially developing the new cancer therapy for the treatment of metastatic prostate cancer, with a pipeline of additional development programs for other solid tumor cancers. Our proprietary therapy was conceived by the focal prostate cancer therapy pioneer and inventor of the male lumpectomy, Gary Onik, M.D. He is not only the inventor, but also a patient. Dr. Onik developed aggressive metastatic prostate cancer in 2018 and received his own therapy. He had a complete response and remains disease-free to date. ImmunSYS is committed to bringing life-changing treatments to cancer patients by bringing the tumor to the immune system to fight cancer in a new way. We believe our new YourVaccx™ therapy has the potential to offer cancer patients substantial benefits over the existing standard of care, including the potential for cure in some patients.

InNeuroCo's mission is to create and deliver high-quality complex catheter solutions. Dedicating time and resources to design and develop safe revolutionary technology, which industry leaders and doctors not only approve of . . . but also depend on. ​InNeuroCo brings together brilliant minds in science and engineering with access to the most advanced neurovascular technologies to build life-saving medical devices that go the distance. When it comes to your life, we don't outsource our materials outside of the U.S. We insource high caliber U.S.-made materials to ensure high quality and safety because your life depends on it.

As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries and regions. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. Santen Pharmaceutical Official Social Media Global Terms of Use​ https://www.santen.com/en/legal/

IMI is the industry leader in tamper evident technologies for IV syringes, oral dispensers and other delivery systems. We have been providing innovative products for admixture, compounding and nuclear pharmacies for over 40 years. IMI manufacturers a complete line of sterile adapters, caps and plugs in addition to a variety of aspiration and venting needles. Each are manufactured to exacting standards right here in the USA. IMI has obtained Certifications to meet the requirements for ISO 13485:2003: CMDCAS & Medical Devices Directive 93/42/EEC

At Pacira Biosciences, Inc., we are driving innovation to provide ways to manage pain safely and effectively. iovera° is a patented, 510(k)-cleared medical device, which uses targeted cryoanalgesia for immediate and long-lasting pain relief. iovera° treats peripheral nerves to temporarily stop pain signals for up to 90 days and provides pain relief until the nerve regenerates and nerve signaling is restored through an innovative handheld design. The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue. iovera° should not be used for people with: cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud's disease, open and/or infected wounds at or near treatment site. Patients treated with iovera° (a needle-based therapy) may have certain reactions, including but not limited to bruising, swelling, inflammation and/or redness, local pain and/or tenderness, altered feeling at application site. Proper iovera° use (see User Guide) can help reduce or prevent these reactions: in treatment area(s) – skin damage from being exposed to cold/heat, skin darkening/lightening, skin dimples; outside treatment area(s) – muscles may not work/move normally. Adverse event reporting: email drugsafety@pacira.com or call 1-855-793-9727. Product quality complaints: email drugsafety@pacira.com or call 1-800-442-0989. Please don't report such information through this or other social media pages owned by Pacira Biosciences, Inc. If you do report through this page, Pacira reserves the right to contact you for information.

LENSAR® is the leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision and accuracy, while optimizing overall visual outcomes. The proprietary Augmented Reality™, LENSAR’s reconstructed 3-D imaging, measurement, and guidance system, provides high-resolution ocular images in a single scan. This technology facilitates precise surgical incisions and treatment for ultimate accuracy and reliable outcomes, all in a single procedure room. The LENSAR Laser System is the only femtosecond cataract laser built specifically for refractive cataract surgery. Because it was designed from the ground up, every aspect of the laser has been purposefully designed to meet the needs of cataract surgeons. LENSAR, Inc. is committed to revolutionizing refractive eye surgery. Our success depends on talented and motivated individuals who share our passion for making a difference in patients’ lives. We are a young and vibrant company located in Orlando, FL. We pride ourselves on having a highly collaborative, innovative environment where initiatives and teamwork are valued and individual efforts are recognized. If you’re looking for a career that enables you to pursue both professional and personal goals, we invite you to consider a career at LENSAR, Inc. Click on our website link below for current employment opportunities. Interested in learning more? Contact us at marketing@lensar.com

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

MMI ia an incubated entity in Mergenet Solutions, Inc.

Neocis, the first dental robotics company, is committed to enhancing dental surgeons’ capabilities and advancing patient care. Or Yomi is bringing the power of surgical robotics to dentistry.

Noble manufactures and commercializes training devices that mimic the exact feel, force and function of drug delivery devices such as autoinjectors, prefilled syringes, on body, nasal and pulmonary devices in order to increase patient adherence and confidence, and decrease usage errors. Noble is an Aptar Pharma company, which is part of AptarGroup, Inc. (NYSE:ATR).

OBVIUS Robotics, Inc. is a medical device company based in South Florida, founded in 2020. The company focuses on developing innovative technology to enhance vascular access procedures, particularly central line placements. The inspiration for OBVIUS Robotics came from a critical care physician's experience with the challenges of central line placement in patients with complex anatomy. The flagship product, the CERTA Access System, is a handheld image-guided needle placement device designed to improve the accuracy and safety of central venous catheterization (CVC) procedures. This user-friendly device allows clinicians of all experience levels to visualize target vessels and perform needle placements quickly and effectively. The CERTA Access System has achieved significant clinical success, with a 100% access success rate in initial cases and has received FDA Breakthrough Device Designation, indicating its potential to enhance patient care. OBVIUS Robotics is dedicated to making vascular access more reliable and efficient for healthcare providers.

OrthoNovis is a medical device company that offers physicians and healthcare facilities the ability to purchase high quality products direct from the manufacturer. The OrthoNovis "direct to consumer" business model allows us to deliver innovative products at a price below other comparable products in the market. That is our GoDIRECT® Advantage!

The next generation of wound care products won't only cover your wounds, they'll actively kill bacteria and help your body heal itself. We research & develop long-lasting antimicrobial wound care products with no bacterial resistance. Recently granted FDA cleared and patent approval.

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Aspiration System*, which includes a novel aspiration pump and catheters to allow rapid and consistent removal of blood clots from the brain. The RapidPulse logo and the word mark RapidPulseTM are trademarks of RapidPulse, Inc., and are the subject of applications pending in the United States and internationally. *The RapidPulseTM Aspiration System is not cleared for sale in the United States.

RemSleep creates products for sleep apnea and other sleep disorders. Now selling ResPlus CPAP machines. The soon to be FDA cleared, Deltawave device provides maximum airflow with minimum noise. it is the most comfortable interface on the market.

RTI Surgical (RTI) is a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. We focus on specialized clinical segments, including breast and plastic surgery, sports medicine and orthopedics, and neuro and spine surgery. Our Mission is to enhance patients' lives by creating the best clinical outcomes through innovative, high-quality medical solutions.

SafeGuard Surgical provides biodegradable surgical devices that will ensure safer surgery for superior patient outcomes while reducing costs, preventing additional surgical interventions and reducing patient length of stay, but most importantly preventing mortality and morbidity which is much too common risk from surgery. Our mission is a scalable and sustainable innovative global outreach to improve surgical outcomes in advanced surgical procedures adapting US ideas in underdeveloped and advancing outcomes in contemporary nations.

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. Offering proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world. TransDermal Infusion delivers HA, Botox, Fillers, Hair Restoration, PRP & more without needles, downtime.

At Theragen, we strive to improve patient care and surgical fusion outcomes via non-invasive therapeutic electrical stimulation, advanced patient insights, and exceptional customer service. Theragen recently launched ActaStim-S, the smallest, most digitally capable, and data-driven non-invasive bone growth stimulator in over 2-decades. ActaStim-S assumed first-mover status by combining all-day wearability, proven capacitive coupling therapy, and automated daily clinical data capture to engage patients, enable compliance, and generate insight reports to inform clinicians when patients need guidance to stay on their healing journey.

U.S. Stem Cell, Inc. is a leader in regenerative medicine and is committed to providing autologous cell therapies for the treatment of degenerative conditions. The company specializes in the development of proprietary, physician-based stem cell therapies; novel regenerative solutions, including its lead product AdipoCell™; physician training and certification; veterinary applications; stem cell banking; as well as creating and managing new stem cell clinics. In the past 20 years, to the company’s knowledge, U.S. Stem Cell, Inc. has completed more clinical treatments than any other regenerative care provider in the world. With more than 700 physicians trained and certified with the company, U.S. Stem Cell, Inc. boasts the largest network of physicians working together to continue its mission of harnessing the body’s own ability to heal from within to treat a wide variety of conditions and to improve quality of life.

U.S. Stem Cell, Inc. is a leader in regenerative medicine and is committed to providing autologous cell therapies for the treatment of degenerative conditions. The company specializes in the development of proprietary, physician-based stem cell therapies; novel regenerative solutions, including its lead product AdipoCell™; physician training and certification; veterinary applications; stem cell banking; as well as creating and managing new stem cell clinics. In the past 20 years, to the company’s knowledge, U.S. Stem Cell, Inc. has completed more clinical treatments than any other regenerative care provider in the world. With more than 700 physicians trained and certified with the company, U.S. Stem Cell, Inc. boasts the largest network of physicians working together to continue its mission of harnessing the body’s own ability to heal from within to treat a wide variety of conditions and to improve quality of life.